Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
18 Noviembre 2024 - 5:00AM
Business Wire
Former FDA deputy commissioner and former
Pfizer & Hillrom quality executive join Hims & Hers,
deepening the leadership that drives the company’s high standard of
quality and safety
Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS),
the leading health and wellness platform, today announced Deb
Autor, former deputy commissioner at the FDA, will join the
company’s board of directors, and Janet Stevens, a pharmaceutical
quality expert, will join the company as Global Head of Quality
& Safety. Hims & Hers continues to prioritize safety across
its platform, offerings, and leadership so that every customer can
have the confidence that the solutions they have access to are
safe, high-quality, and personalized for their needs.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20241118954274/en/
Former FDA deputy commissioner and former
Pfizer & Hillrom quality executive join Hims & Hers,
deepening the leadership that drives the company’s high standard of
quality and safety. (Photo: Business Wire)
Autor brings more than 30 years of experience across
pharmaceutical quality and compliance, regulatory programs, and
consumer protection to Hims & Hers. She previously served as
the Deputy Commissioner for Global Regulatory Operations and Policy
at the FDA, where she oversaw FDA inspections, criminal
investigations, and international operations for the agency. She
also served as the agency’s Director of the Office of Compliance
for the Center for Drug Evaluation and Research, leading
enforcement for drug requirements. As a trial attorney for the
Department of Justice, the FDA was her primary client. She has also
served as the Global Head of Regulatory Excellence at AstraZeneca
and is currently the CEO of Healthcare Innovation Catalysts.
Stevens has spent her entire career in pharmaceutical quality
assurance, operations, and engineering. She joins Hims & Hers
from Hillrom, where she served as the Chief Quality Officer,
helping the company achieve top-quartile results in global quality
regulations. She also served as Pfizer’s Vice President of Sterile
Injectable Quality Operations, where she led the company’s quality
organizations and enabled successful regulatory inspections
globally with regulatory authorities like the FDA, MHRA, and Health
Canada.
“We’ve built a customer experience that prioritizes clinical
excellence and the highest standard of safety and quality for every
person who trusts us with their journey,” said Andrew Dudum, CEO
and co-founder of Hims & Hers. “The depth of expertise Deb and
Janet bring to the team is incredibly valuable as we continue to
scale our operations to meet the needs of the growing number of
customers who come to our platform seeking healthcare solutions
that fit their individual needs.”
“Affordable, accessible, convenient healthcare for US consumers
is lacking, and Hims & Hers is addressing that need,” said Deb
Autor. “In my many decades in the healthcare field, this is the
first company I’ve seen achieving scale, impact, and quality while
pushing innovation in the service of patients. This is an exciting
moment and I’m thrilled to be part of it.”
“Customers put an immense amount of trust in healthcare
companies, and Hims & Hers is one of the few companies doing
the meaningful work to earn that trust,” said Janet Stevens. “The
safety of our operations is the foundation of connection we have
with our customers. Continuing to strengthen that connection will
be a critical part of impacting more lives on our platform.”
Autor joins health and pharmaceutical industry experts on the
Hims & Hers Board of Directors including: former Novo Nordisk
executive, Kåre Schultz; former CEO of the Cleveland Clinic, Dr.
Toby Cosgrove; US regulatory and foreign policy expert, Anja
Manuel; and former Chief Medical Officer of Walgreens and current
Chief Medical Officer of Hims & Hers, Patrick Carroll, amongst
others.
About Hims & Hers Health, Inc.
Hims & Hers is the leading health and wellness platform on a
mission to help the world feel great through the power of better
health. We believe how you feel in your body and mind transforms
how you show up in life. That’s why we’re building a future where
nothing stands in the way of harnessing this power. Hims & Hers
normalizes health & wellness challenges—and innovates on their
solutions—to make feeling happy and healthy easy to achieve. No two
people are the same, so the company provides access to personalized
care designed for results. For more information, please visit
www.hims.com and www.forhers.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241118954274/en/
Press Contact Abby Reisinger press@forhims.com
Hims and Hers Health (NYSE:HIMS)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Hims and Hers Health (NYSE:HIMS)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024